Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study

Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study-A Randomized Clinical Trial

(2016) A. Boswood et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Risk Factors for Coughing in Dogs with Naturally Acquired Myxomatous Mitral Valve Disease

(2013) L. Ferasin et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

(2013) J. Häggström et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Efficacy of Pimobendan in the Prevention of Congestive Heart Failure or Sudden Death in Doberman Pinschers with Preclinical Dilated Cardiomyopathy (The PROTECT Study)

(2012) N.J. Summerfield et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease

(2012) Melanie J. Hezzell et al.   Journal of Veterinary Cardiology

Prediction of first onset of congestive heart failure in dogs with degenerative mitral valve disease: The PREDICT cohort study

(2012) Caryn A. Reynolds et al.   Journal of Veterinary Cardiology

Effects of treatment on respiratory rate, serum natriuretic peptide concentration, and Doppler echocardiographic indices of left ventricular filling pressure in dogs with congestive heart failure secondary to degenerative mitral valve disease and dilated cardiomyopathy

(2011) Karsten E. Schober et al.   JAVMA-JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION

Rate of change of heart size before congestive heart failure in dogs with mitral regurgitation

(2010) P. Lord et al.   JOURNAL OF SMALL ANIMAL PRACTICE

N-terminal pro B-type natriuretic peptide and left ventricular diameter independently predict mortality in dogs with mitral valve disease

(2010) W. Moonarmart et al.   JOURNAL OF SMALL ANIMAL PRACTICE

Effect of Pimobendan or Benazepril Hydrochloride on Survival Times in Dogs with Congestive Heart Failure Caused by Naturally Occurring Myxomatous Mitral Valve Disease: The QUEST Study

(2009) J. Häggström et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Guidelines for the Diagnosis and Treatment of Canine Chronic Valvular Heart Disease

(2009) C. Atkins et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Survival Characteristics and Prognostic Variables of Dogs with Mitral Regurgitation Attributable to Myxomatous Valve Disease

(2008) M. Borgarelli et al.   JOURNAL OF VETERINARY INTERNAL MEDICINE

Handling drop-out in longitudinal clinical trials: a comparison of the LOCF and MMRM approaches

(2007) Peter Lane   PHARMACEUTICAL STATISTICS